<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Ovarian Cancer Trial May Help 30% More Patients
Image Overlay - Ovarian Cancer Trial May Help 30% More Patients

Ovarian Cancer Trial May Help 30% More Patients

October 16, 2019

Ovarian Cancer Trial May Help 30% More Patients

Cancer patients at the Sylvester Comprehensive Cancer Center that participated in a clinical trial for ovarian cancer have impacted the way the disease is understood. The study proved that an anti-cancer drug called veliparib, which targets the way DNA repairs itself, might help up to 30% more patients. Yourway increases access to life-saving medicine by being on the forefront of the clinical trial supply chain.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?